Start Combination Therapy Earlier, ADA Says

Metformin is the typical first-line treatment for people with type 2 diabetes, but the ADA suggests early combination therapy with other medications should be used in patients with type 2 diabetes and chronic kidney disease or cardiovascular disease. Read more

Weight at Birth Linked to Type 2 Risk

A birthweight of 2.5 kg (about 5.5 pounds) or more is linked to increased risk of developing type 2 diabetes later in life, researchers say. A person’s susceptibility to type 2 diabetes is determined by various risk factors over the course of their lives. Read more

Intermittent vs. Continuous Calorie Restriction

A recent study compared the effects of intermittent energy restriction (IER) or continuous energy restriction (CER) on participants with overweight or obesity, to see which has a more significant effect on weight loss. IER consisted of periods of a low energy diet of 500 to 600 kcal, alternating with periods of unrestricted food intake, versus […]

Diabetes Among Factors that Cause 2/3 of COVID-19 Hospitalizations

About 64% of adults hospitalized with COVID-19 had one or more of four underlying conditions, researchers say: obesity, diabetes, hypertension, and heart failure. This reinforces other studies which have found these conditions are strongly linked to poor COVID-19 outcomes. Read more

Can Electromagnetic Fields Treat Diabetes?

Electromagnetic fields (EMFs) might be a safe and non-invasive way to manage blood glucose in diabetes, say researchers who examined the effects of EMFs in altering the balance of oxidants and antioxidants in the liver and causing an improvement in the body’s response to insulin. Read more

Vitamin D Deficiency Does Not Increase Type 1 Risk

The possible role of Vitamin D levels contributing to diabetes risk has been much discussed. A recent study has found that deficiencies in Vitamin D are not linked to an increased risk of developing type 1 diabetes in Europeans. Read more

For COVID-19 Mortality, Type 2 Diabetes “Adds 20 Years” to Age

The risk of dying from COVID-19 infection is higher in middle-aged adults with type 2 diabetes versus adults without diabetes, and is the equivalent of adding 20 years of chronological age in assessing overall related death risk. Read more

Anemia and A1c

Glycated hemoglobin (A1c) testing is a standard method of assessing blood glucose levels in people with diabetes. However, researchers are finding that iron deficiency or vitamin B12 deficiency anemia can affect A1c testing results. Read more

Prediabetes Can Damage Brain

Diabetes has already been linked with dementia and cognitive decline. Now, researchers say people with prediabetes also have a higher risk of cognitive decline and vascular dementia, even in the absence of full-blown diabetes, stressing the importance of glycemic control in preventing these conditions. Read more

Training Low-Carb and Competing High-Carb

Some athletes now embrace a strategy called “low CHO availability“ to potentially improve their performance, which involves training low-carb and competing high-carb — periodically doing endurance training with reduced carbohydrate availability, but competing without carbohydrate intake restrictions. Diabetes exercise expert Dr. Sheri Colberg takes a closer look at the implications. Read more

Stress, Mood Issues Worse in Younger Patients with Diabetes, Sleep Apnea

Obstructive sleep apnea (OSA), insomnia, and diabetes are often linked and can have an impact on quality of life, worsening the risk for stress and depression. New research suggests the impact is worse on people under the age of sixty-five who experience diabetes and OSA. Read more

More Evidence for Heart Benefits of Empagliflozin

Studies of diabetes drugs empagliflozin and dapagliflozin, both in the SGLT-2 inhibitor class, have shown they help reduce cardiovascular risk for diabetes patients. Now, researchers have found that empagliflozin is beneficial for the heart in people without diabetes as well. Read more

How New Technologies Have Changed Living with Type 1 Diabetes

Technology has changed managing type 1 diabetes dramatically over the last 20 years, for both children and adults. Good glucose management is key to preventing many complications of diabetes, and this has been made much easier with the use of continuous glucose monitors, new pump designs, and closed-loop systems. Read more

Does Your Pet’s Diabetes Increase Your Own Risk?

Having a dog that is diagnosed with diabetes was related to a increased risk of type 2 diabetes in the owner, a recent study found. Potential causes of this link in dog-owner pairs might possibly have something to do with shared health habits, such as physical activity level, and shared environmental exposures. Read more

People with Diabetes Should Be Prioritized for COVID-19 Vaccine at 40+

People with diabetes are at higher risk of death from the COVID-19 virus at younger ages than people without diabetes, researchers say, and should be prioritized for the vaccine from age 40 and up. Read more

Once-Weekly Semaglutide May Assist with Weight Loss

The diabetes drug semaglutide, administered once-weekly subcutaneously and used in conjunction with lifestyle modifications, helped people with overweight or obesity achieve sustained, significant reductions in body weight. Read more

Clinical Trial for Possible New Type 1 Treatment

A clinical trial of a new stem cell-derived pancreatic islet cell treatment for type 1 diabetes, by Vertex Pharmaceuticals, is moving forward. According to Vertex, the therapy, called VX-880, has the potential to restore the body’s ability to normalize blood glucose levels through restoration of pancreatic islet cell function. Read more

Social Deprivation Increases Risk for Diabetic Foot Complications

People who suffer from social deprivation, which can be caused by factors including poverty and mental illness, and who have type 2 diabetes are at greater risk for complications of diabetic foot disease, including diabetic foot ulcers, lower limb amputation, and gangrene. Read more

The Role of Weak and Strong Cells in Insulin Production

Type 2 diabetes is the condition that results when β-cells (beta cells) cannot release enough insulin for the body’s needs. A group of researchers say they have new insight into how “weak” beta cells bond with other, more mature cells to boost insulin production, which can help us understand more about the processes that lead […]

Type 2 Increases Liver Disease Risk

Some metabolic conditions, including type 2 diabetes, can increase the risk of severe non-alcoholic fatty liver disease (NAFLD), a condition which can cause inflammation, cirrhosis, and possibly liver cancer. People with type 2 diabetes have twice the risk of severe liver disease than people without type 2, researchers say. Read more

Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner